Join us for a webinar on May 30, hosted with @cancercolab and @nrc_cnrc, to explore the potential of viral vectors in emerging cancer therapies. Register today:

BioCanRx is proud to support Unlocking Next-Gen Therapies on May 9 with @CancerResrch + @PICInnovates. Dr. Natasha Kekre will share Canada's CLIC CAR T model + regulatory needs for cell therapies.

Applications for 2025-2026 Travel & Lab Exchange Awards are now open! For more information, visit

#BioCanRx est fier d’investir 12,5 M$ dans 20 projets de recherche + 4 installations principales pour faire avancer les traitements en #immunothérapie du #cancer et stimuler l’innovation canadienne en biothérapeutique!.En savoir plus.#FaitAuCanada.

#BioCanRx is proud to invest $12.5M in 20 research projects + 4 core facilities to advance #immunotherapy treatments for #cancer and drive Canadian innovation in biotherapeutics!.Learn more: #MadeInCanada.

Reserve your spot today - the Summit for Cancer Immunotherapy starts in one month! Register today at Don't forget to reserve your room at the Westin Harbour Castle before March 13 to benefit from discounted group rates. #Summit4CI #BioCanRx

BioCanRx is pleased to announce that Russell Williams has been elected as Chair of the Board of Directors. For more information on Russell Williams our Board of Directors please visit our website:

Le réseau BioCanRx est heureux d'annoncer que Russell Williams a été élu président du conseil d'administration. Pour obtenir de plus amples renseignements sur Russell Williams, veuillez consulter notre site Web:

RT @pauljerardl: Great to see a marvellous Patient Scholar, Cynthia Mitchell, from ⁦@CancerCareMBFdn ⁦@CancerCareMB⁩ participating at the ⁦….

Registration for the Summit for Cancer Immunotherapy closes in one month! Spots are going quickly - register to secure yours today. #Summit4CI #SummitforCancerImmunotherapy #Summit4CI2025 #CancerImmunotherapy #CanadaCancerResearch #BioCanRx

Are you at @AAASmeetings? Join BioCanRx, @GenomeCanada and the @Perimeter Institute at the Canada Pavilion at 2pm Friday to learn about our efforts to power breakthroughs in genomics and immunotherapy, shape policy, and bring hope to patients faster. #aaasmtg #CdnSci #SciPol.

La fabrication de traitements d'immunothérapie contre le cancer au point d’intervention pourrait rendre ces traitements accessibles à un plus grand nombre de Canadiens, plus rapidement. Lire la suite:

Manufacturing cancer immunotherapy treatments at the point of care could make these treatments accessible to more Canadians, faster. Read the full article on our website:

RT @OttawaHospital: Researchers have developed a novel approach to create tiny “mobile pharmacies” that can get inside tumours and dispense….

We invite Indigenous undergraduate and college students to apply for the BioCanRx Indigenous Students Summer Internship Program, offered with our partner @Indspire and supported by the @cancersociety and @OICR_news! .

In Their Own Words features our researchers, their work, and their hopes for Canadian cancer immunotherapy. Today, meet Jennifer Quizi from the OHRI Biotherapeutics Manufacturing Centre (BMC). Visit for the full interview!.

Notre série « Dans leurs propres mots » présente nos chercheurs, leur travail et leurs espoirs pour l'immunothérapie du cancer au Canada. Aujourd'hui, voici Jennifer Quizi. Visitez le site pour lire l'intégralité de l'entrevue !.

Apply now for the BioCanRx Summer Student Internships! This funding opportunity is open to undergraduates and college students attending Canadian institutions, and to BioCanRx network investigators. For more information, and to apply, visit our website:

Dans leurs mots : Megan Levings parle de son travail, de ses objectifs et de ses espoirs pour l'immunothérapie du cancer au Canada. Lire l'intégralité de l'entretien ici : 

In their words: Megan Levings talks about her work, her goals, and her hopes for cancer immunotherapy in Canada. Read the full interview here: